Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToNetincome,capitalExpenditures,otherCashflowsFromFinancingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,gmtOffSetMilliseconds,esgPopulated,tradeable,market,exchange,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,priceHint,marketState,exchangeDataDelayedBy,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry
t0,ELVAF,21198000.0,806729984,3290000,,-8176050,,-8176950,2168500,421800,-5036700,-5036700,,-109550,,,,900,1788500,6825200,1366700,-3139350,,-8176950,-8176950,83854600.0,355082600.0,21800800.0,145092100.0,1349100.0,166892900.0,41093900.0,422700.0,-286391600.0,2483600.0,40039500.0,35307200.0,2177700.0,19669400.0,15138700.0,39016400.0,6914200.0,33576800.0,330100.0,2649000.0,9125300.0,2128300.0,900.0,-2446000.0,4737550.0,4737550.0,-1066550.0,-2806800.0,-55050.0,-5043300.0,1838550.0,2900.0,2267500.0,-261900.0,,18438100.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.0,0.2045 - 0.2045,0.2045,0.0,0.0,0,0,finmb_3272498,Other OTC,Evolva Holding SA,CHF,3284,500,-14400000,False,False,us_market,PNK,-0.041,0.18,0.19575,0.008750007,0.044699907,0.2181087,-0.013608694,-0.06239409,164976288,1.1361111,15,America/New_York,EDT,0.2045,1629834359,0.0,0.2045,0.2045,0.2045,10,EVOLVA HOLDING SA,4,REGULAR,0,0.034500003,0.2029412,0.17 - 0.32,-0.11549999,-0.36093748,0.17,0.32,0.89,,,0.32,0.17,0.1957,0.2181,3.28k,500,806.73M,,805.93M,2.65%,18.96%,,,,,,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",0.00%,-291.81%,-7.66%,-18.81%,7.54M,0.01,-31.60%,658.2k,-15.27M,-29.87M,-0.0410,,19.67M,0.02,9.02M,6.22,2.22,0.18,-23.36M,-16.46M,Value,4153,Healthcare,70,"Evolva Holding SA discovers, develops, and commercializes ingredients for use in food, nutrition, personal healthcare, agriculture, and other sectors in Switzerland, the United States, and internationally. It offers branded ingredients, such as Veri-te Resveratrol, a natural ingredient in grapes, as well as other plants, including peanuts, cranberries, and Japanese knotweed for use in age-related health conditions; Nootkashield for pest control applications; EverSweet Stevia, a sweetener use in food, beverages, and table-top sweeteners; Nootkatone, an ingredient for flavour and fragrance applications; Valencene, an aroma ingredient; and Vanillin, an extracted from the seed pods of the vanilla orchid and is made up of a complex mixture of taste components. It serves the nutrition, flavors and fragrances, animal health, personal care, and pharmaceutical markets. The company was founded in 2004 and is headquartered in Reinach, Switzerland.",Reinach,41 61 485 2000,1609372800,Switzerland,http://www.evolva.com,86400,Duggingerstrasse 23,41 61 485 2001,Biotechnology
t-1,ELVAF,21198000.0,806729984,3290000,,-8176050,,-8176950,2168500,421800,-5036700,-5036700,,-109550,,,,900,1788500,6825200,1366700,-3139350,,-8176950,-8176950,83854600.0,355082600.0,21800800.0,145092100.0,1349100.0,166892900.0,41093900.0,422700.0,-286391600.0,2483600.0,40039500.0,35307200.0,2177700.0,19669400.0,15138700.0,39016400.0,6914200.0,33576800.0,330100.0,2649000.0,9125300.0,2128300.0,900.0,-2446000.0,4737550.0,4737550.0,-1066550.0,-2806800.0,-55050.0,-5043300.0,1838550.0,2900.0,2267500.0,-261900.0,,18438100.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.0,0.2045 - 0.2045,0.2045,0.0,0.0,0,0,finmb_3272498,Other OTC,Evolva Holding SA,CHF,3284,500,-14400000,False,False,us_market,PNK,-0.041,0.18,0.19575,0.008750007,0.044699907,0.2181087,-0.013608694,-0.06239409,164976288,1.1361111,15,America/New_York,EDT,0.2045,1629834359,0.0,0.2045,0.2045,0.2045,10,EVOLVA HOLDING SA,4,REGULAR,0,0.034500003,0.2029412,0.17 - 0.32,-0.11549999,-0.36093748,0.17,0.32,0.89,,,0.32,0.17,0.1957,0.2181,3.28k,500,806.73M,,805.93M,2.65%,18.96%,,,,,,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",0.00%,-291.81%,-7.66%,-18.81%,7.54M,0.01,-31.60%,658.2k,-15.27M,-29.87M,-0.0410,,19.67M,0.02,9.02M,6.22,2.22,0.18,-23.36M,-16.46M,Value,4153,Healthcare,70,"Evolva Holding SA discovers, develops, and commercializes ingredients for use in food, nutrition, personal healthcare, agriculture, and other sectors in Switzerland, the United States, and internationally. It offers branded ingredients, such as Veri-te Resveratrol, a natural ingredient in grapes, as well as other plants, including peanuts, cranberries, and Japanese knotweed for use in age-related health conditions; Nootkashield for pest control applications; EverSweet Stevia, a sweetener use in food, beverages, and table-top sweeteners; Nootkatone, an ingredient for flavour and fragrance applications; Valencene, an aroma ingredient; and Vanillin, an extracted from the seed pods of the vanilla orchid and is made up of a complex mixture of taste components. It serves the nutrition, flavors and fragrances, animal health, personal care, and pharmaceutical markets. The company was founded in 2004 and is headquartered in Reinach, Switzerland.",Reinach,41 61 485 2000,1609372800,Switzerland,http://www.evolva.com,86400,Duggingerstrasse 23,41 61 485 2001,Biotechnology
t-2,ELVAF,28959100.0,806729984,3487800,,-6768050,,-6758150,2385150,-92700,-5965650,-5965650,,-155700,,,,-9900,1981850,7947500,2074550,-802400,,-6758150,-6758150,87889000.0,356067100.0,18696600.0,158642100.0,1139400.0,177338700.0,41093900.0,,-270001400.0,2417400.0,41794000.0,31482500.0,2186500.0,25283000.0,11785600.0,42242700.0,7128600.0,38340600.0,,3164000.0,7053900.0,2152000.0,0.0,-353550.0,-260350.0,-309650.0,-2320200.0,-7318400.0,-17150.0,-6638050.0,2069500.0,-1750.0,286150.0,-351800.0,-49300.0,26555000.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.0,0.2045 - 0.2045,0.2045,0.0,0.0,0,0,finmb_3272498,Other OTC,Evolva Holding SA,CHF,3284,500,-14400000,False,False,us_market,PNK,-0.041,0.18,0.19575,0.008750007,0.044699907,0.2181087,-0.013608694,-0.06239409,164976288,1.1361111,15,America/New_York,EDT,0.2045,1629834359,0.0,0.2045,0.2045,0.2045,10,EVOLVA HOLDING SA,4,REGULAR,0,0.034500003,0.2029412,0.17 - 0.32,-0.11549999,-0.36093748,0.17,0.32,0.89,,,0.32,0.17,0.1957,0.2181,3.28k,500,806.73M,,805.93M,2.65%,18.96%,,,,,,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",0.00%,-291.81%,-7.66%,-18.81%,7.54M,0.01,-31.60%,658.2k,-15.27M,-29.87M,-0.0410,,19.67M,0.02,9.02M,6.22,2.22,0.18,-23.36M,-16.46M,Value,4153,Healthcare,70,"Evolva Holding SA discovers, develops, and commercializes ingredients for use in food, nutrition, personal healthcare, agriculture, and other sectors in Switzerland, the United States, and internationally. It offers branded ingredients, such as Veri-te Resveratrol, a natural ingredient in grapes, as well as other plants, including peanuts, cranberries, and Japanese knotweed for use in age-related health conditions; Nootkashield for pest control applications; EverSweet Stevia, a sweetener use in food, beverages, and table-top sweeteners; Nootkatone, an ingredient for flavour and fragrance applications; Valencene, an aroma ingredient; and Vanillin, an extracted from the seed pods of the vanilla orchid and is made up of a complex mixture of taste components. It serves the nutrition, flavors and fragrances, animal health, personal care, and pharmaceutical markets. The company was founded in 2004 and is headquartered in Reinach, Switzerland.",Reinach,41 61 485 2000,1609372800,Switzerland,http://www.evolva.com,86400,Duggingerstrasse 23,41 61 485 2001,Biotechnology
t-3,ELVAF,28959100.0,806729984,3487800,,-6768050,,-6758150,2385150,-92700,-5965650,-5965650,,-155700,,,,-9900,1981850,7947500,2074550,-802400,,-6758150,-6758150,87889000.0,356067100.0,18696600.0,158642100.0,1139400.0,177338700.0,41093900.0,,-270001400.0,2417400.0,41794000.0,31482500.0,2186500.0,25283000.0,11785600.0,42242700.0,7128600.0,38340600.0,,3164000.0,7053900.0,2152000.0,0.0,-353550.0,-260350.0,-309650.0,-2320200.0,-7318400.0,-17150.0,-6638050.0,2069500.0,-1750.0,286150.0,-351800.0,-49300.0,26555000.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.0,0.2045 - 0.2045,0.2045,0.0,0.0,0,0,finmb_3272498,Other OTC,Evolva Holding SA,CHF,3284,500,-14400000,False,False,us_market,PNK,-0.041,0.18,0.19575,0.008750007,0.044699907,0.2181087,-0.013608694,-0.06239409,164976288,1.1361111,15,America/New_York,EDT,0.2045,1629834359,0.0,0.2045,0.2045,0.2045,10,EVOLVA HOLDING SA,4,REGULAR,0,0.034500003,0.2029412,0.17 - 0.32,-0.11549999,-0.36093748,0.17,0.32,0.89,,,0.32,0.17,0.1957,0.2181,3.28k,500,806.73M,,805.93M,2.65%,18.96%,,,,,,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",0.00%,-291.81%,-7.66%,-18.81%,7.54M,0.01,-31.60%,658.2k,-15.27M,-29.87M,-0.0410,,19.67M,0.02,9.02M,6.22,2.22,0.18,-23.36M,-16.46M,Value,4153,Healthcare,70,"Evolva Holding SA discovers, develops, and commercializes ingredients for use in food, nutrition, personal healthcare, agriculture, and other sectors in Switzerland, the United States, and internationally. It offers branded ingredients, such as Veri-te Resveratrol, a natural ingredient in grapes, as well as other plants, including peanuts, cranberries, and Japanese knotweed for use in age-related health conditions; Nootkashield for pest control applications; EverSweet Stevia, a sweetener use in food, beverages, and table-top sweeteners; Nootkatone, an ingredient for flavour and fragrance applications; Valencene, an aroma ingredient; and Vanillin, an extracted from the seed pods of the vanilla orchid and is made up of a complex mixture of taste components. It serves the nutrition, flavors and fragrances, animal health, personal care, and pharmaceutical markets. The company was founded in 2004 and is headquartered in Reinach, Switzerland.",Reinach,41 61 485 2000,1609372800,Switzerland,http://www.evolva.com,86400,Duggingerstrasse 23,41 61 485 2001,Biotechnology
